Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Q1 Domestic PDT Revenues Up 26% Year-Over-Year; Company Achieves Record Domestic BLU-U® Sales Volumes Conference Call and Audio Webcast Will Be Held Today, May 8th, at 8:30am...
-
WILMINGTON, Mass., May 1, 2012 (GLOBE NEWSWIRE) -- DUSA Pharmaceuticals, Inc. (Nasdaq:DUSA) announces that its first quarter 2012 corporate highlights and financial results press release will be...
-
WILMINGTON, Mass., April 24, 2012 (GLOBE NEWSWIRE) -- DUSA Pharmaceuticals, Inc.® (Nasdaq:DUSA), a dermatology company that is developing and marketing its Levulan® Photodynamic Therapy...
-
WILMINGTON, Mass., April 10, 2012 (GLOBE NEWSWIRE) -- Dermatology company DUSA Pharmaceuticals, Inc.® (Nasdaq:DUSA), today introduced its Teeing Off Against Sun Damage™ campaign. This...
-
WILMINGTON, Mass., March 23, 2012 (GLOBE NEWSWIRE) -- DUSA Pharmaceuticals, Inc.® (Nasdaq:DUSA), a dermatology company that is developing and marketing Levulan® Photodynamic Therapy (PDT),...
-
WILMINGTON, Mass., March 19, 2012 (GLOBE NEWSWIRE) -- DUSA Pharmaceuticals, Inc.® (Nasdaq:DUSA), a dermatology company that is developing and marketing Levulan® Photodynamic Therapy (PDT),...
-
Campaign and New Website www.spotsignsofAK.com Launched Today During American Academy of Dermatology Annual Meeting WILMINGTON, Mass., March 16, 2012 (GLOBE NEWSWIRE) -- Dermatology company DUSA...
-
WILMINGTON, Mass., March 7, 2012 (GLOBE NEWSWIRE) -- DUSA Pharmaceuticals, Inc.® (Nasdaq:DUSA), a dermatology company that is developing and marketing Levulan® Photodynamic Therapy (PDT),...
-
Record Fourth Quarter Revenues Drive Significant Income and Cash Flow Improvements Year-Over-Year Fourth Quarter Highlighted by 30% Domestic Kerastick® Revenue Growth Conference Call and...
-
WILMINGTON, Mass., Feb. 28, 2012 (GLOBE NEWSWIRE) -- DUSA Pharmaceuticals, Inc. (Nasdaq:DUSA) announces that its fourth quarter and full year 2011 corporate highlights and financial results press...